Other biomarkers MCP1 (OR = 2.19, CI95 [1.8–2.6], p < 0.0001), CRP (OR = 1.89, [1.6–2.3], p < 0.0001), IL6 (OR = 2.11, [1.4–3.1], p = 0.0002), sICAM1 (OR = 1.61, [1.4–1.9], p < 0.0001), and fibrinogen (OR = 1.86, [1.2–2.9], p = 0.0066) had also significant odds for participants being in the top 75% quartile of the biomarker distribution and classified as having the NCEP MetS. Here, CCL2 is linked to metabolic syndrome.